Tumor Microenvironment–Responsive Polypeptide Nanogels for Controlled Antitumor Drug Delivery

4Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Tumor microenvironment–responsive polypeptide nanogels belong to a biomaterial with excellent biocompatibility, easily adjustable performance, biodegradability, and non-toxic properties. They are developed for selective delivery of antitumor drugs into target organs to promote tumor cell uptake, which has become an effective measure of tumor treatment. Endogenous (such as reduction, reactive oxygen species, pH, and enzyme) and exogenous (such as light and temperature) responsive nanogels can release drugs in response to tumor tissues or cells to improve drug distribution and reduce drug side effects. This article systematically introduces the research progress in tumor microenvironment–responsive polypeptide nanogels to deliver antitumor drugs and provides a reference for the development of antitumor nanoformulations.

Cite

CITATION STYLE

APA

Liu, Y., Chen, L., Shi, Q., Zhao, Q., & Ma, H. (2021, October 27). Tumor Microenvironment–Responsive Polypeptide Nanogels for Controlled Antitumor Drug Delivery. Frontiers in Pharmacology. Frontiers Media S.A. https://doi.org/10.3389/fphar.2021.748102

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free